Form 8-K - Current report:
SEC Accession No. 0001628280-18-002154
Filing Date
2018-02-26
Accepted
2018-02-23 17:43:43
Documents
1
Period of Report
2018-02-23
Items
Item 7.01: Regulation FD Disclosure

Document Format Files

Seq Description Document Type Size
1 8-K expenseguidancefeb2018.htm 8-K 28853
  Complete submission text file 0001628280-18-002154.txt   29999
Mailing Address 1900 POWELL ST., SUITE 750 EMERYVILLE CA 94608
Business Address 1900 POWELL ST., SUITE 750 EMERYVILLE CA 94608 510-450-3554
Adamas Pharmaceuticals Inc (Filer) CIK: 0001328143 (see all company filings)

EIN.: 421560076 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36399 | Film No.: 18637938
SIC: 2834 Pharmaceutical Preparations